Comparison of the therapeutic effects of four topical drugs in the treatment of vitiligo
Phase 3
- Conditions
- Vitiligo.Vitiligo
- Registration Number
- IRCT20220117053743N2
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age 16-60 years
Involvement of <20% total body surface area
Lesions on the extremities, trunk, and face
Exclusion Criteria
Follicular pigmentation
White hair in the lesion
Lesions at the distal end of the extremities
Genital, periungual, and skin fold lesions
Topical treatment or phototherpay within the past month
Pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Perifollicular pigmentation improvement. Timepoint: Three months after the initiation of treatments. Method of measurement: 1) mild: 0-25%, 2) moderate: 26-50%, 3) good: 50-75%, 4) excellent: >75%.
- Secondary Outcome Measures
Name Time Method Patient satisfaction with treatments. Timepoint: Three months after the initiation of treatments. Method of measurement: Visual Analogue Scale.;Side effects. Timepoint: During treatments. Method of measurement: Patient reports of observation by the specialist.